Position in ICLR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,737
-$476 QoQ
Shares Held
10
-50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#400
of 422 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Purpose Unlimited Inc. holds $947,457 across 9 Diagnostics & Research names. ICLR ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
3,501 | $793,991 | |
| 2 | A |
Agilent Technologies, Inc.
|
275 | $36,528 | |
| 3 | LH |
Labcorp Holdings Inc.
|
118 | $33,040 | |
| 4 | DHR |
Danaher Corp /De/
|
151 | $28,761 | |
| 5 | WAT |
Waters Corp /De/
|
58 | $21,752 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
26 | $13,034 | |
| 7 | RVTY |
Revvity, Inc.
|
110 | $12,238 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
33 | $6,376 |
All Filings in ICLR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,737 | 10 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,213 | 20 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,750 | 59 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||